Pulse Biosciences Inc (NASDAQ: PLSE) Stock Jumped 1.50% Over A Month – Are There Any Chances Of Growth?

During the last session, Pulse Biosciences Inc (NASDAQ:PLSE)’s traded shares were 0.31 million, with the beta value of the company hitting 1.82. At the end of the trading day, the stock’s price was $17.65, reflecting an intraday gain of 2.98% or $0.51. The 52-week high for the PLSE share is $22.69, that puts it down -28.56 from that peak though still a striking 62.66% gain since the share price plummeted to a 52-week low of $6.59. The company’s market capitalization is $1.09B, and the average intraday trading volume over the past 10 days was 0.15 million shares, and the average trade volume was 166.34K shares over the past three months.

Pulse Biosciences Inc (NASDAQ:PLSE) trade information

Pulse Biosciences Inc (PLSE) registered a 2.98% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.98% in intraday trading to $17.65, hitting a weekly high. The stock’s 5-day price performance is -10.63%, and it has moved by 1.50% in 30 days. Based on these gigs, the overall price performance for the year is 74.93%. The short interest in Pulse Biosciences Inc (NASDAQ:PLSE) is 2.12 million shares and it means that shorts have 10.21 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 16.76%.

PLSE Dividends

Pulse Biosciences Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Pulse Biosciences Inc (NASDAQ:PLSE)’s Major holders

Pulse Biosciences Inc insiders own 71.93% of total outstanding shares while institutional holders control 9.30%, with the float percentage being 33.14%. BLACKROCK INC. is the largest shareholder of the company, while 114.0 institutions own stock in it. As of 2024-06-30, the company held over 1.15 million shares (or 2.0787% of all shares), a total value of $12.83 million in shares.

The next largest institutional holding, with 0.91 million shares, is of VANGUARD GROUP INC’s that is approximately 1.641% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $10.13 million.

Also, the Mutual Funds coming in first place with the largest holdings of Pulse Biosciences Inc (PLSE) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 515.01 shares. This amounts to just over 0.84 percent of the company’s overall shares, with a $9.09 million market value. The same data shows that the other fund manager holds slightly less at 482.23, or about 0.78% of the stock, which is worth about $8.51 million.